Clinical trial Recruiting at 1 site Interventional Ages 21 to 89

Treatment to improve fertilization in infertility cases

Official title: Gamete Treatment to Correct Fertilization Failure

Run by Weill Medical College of Cornell University · NCT01944332 · Data updated 2026-11-12

This study is testing a new way to help couples struggling with infertility by improving the chances of fertilization and embryo development.

Quick facts

Study typeInterventional
Ages21 Years to 89 Years
SexAll
Enrollment1200 (estimated)
SponsorWeill Medical College of Cornell University
Academic / other
Locations1 site (New York, New York)
StatusRecruiting
StartedSeptember 2007
Main results expectedJune 30, 2027
Study endsNovember 30, 2027
Registry record updatedDecember 17, 2025
Trial IDNCT01944332 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates include patients who have experienced complete fertilization failure with standard IVF or have had one prior ICSI treatment cycle.

Probably not a fit

Patients who do not meet the inclusion criteria or those who have undergone IVF without ICSI may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This research focuses on enhancing fertilization rates in patients experiencing infertility due to fertilization failure. The study involves preparing sperm using a membrane permeabilizing agent and injecting it into oocytes, which are then activated to promote embryo development. The efficacy of this gamete treatment will be assessed by monitoring fertilization success and embryo development over a standard culture period. The goal is to provide a viable option for patients who have previously faced fertilization challenges.

Why it matters

Potential benefit: If successful, this approach could significantly improve the chances of conception for patients facing fertilization failure.

How similar studies have gone: Other studies have shown promise with similar gamete treatment approaches, indicating potential for success in this area.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Patients with complete fertilization failure with standard IVF or failure with one prior ICSI treatment cycle

Exclusion Criteria:

* not meeting inclusion criteria
* IVF without ICSI

Where it's running

  • Center fo Reproductive Medicine
    New York, New York, United States
    Recruiting

Study contacts

  • Principal investigator: Gianpiero Palermo, MD, MPH — Weill Medical College of Cornell University
  • Study coordinator: Rodriq Stubbs, NP
  • Email: res2011@med.cornell.edu
  • Phone: 646-962-3276

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.